Market Overview

Futures are ripping higher Monday on reports that the U.S. and Iran have agreed to halt hostilities and will meet Tuesday in Qatar, de-escalating geopolitical risk that pressured markets last week. SpaceX’s addition to the Nasdaq-100 is adding momentum, while a rotation out of mega-cap tech into software, biotech, and speculative names continues. It’s a holiday-shortened week (July 4th Friday), which typically favors risk-on positioning early before volume thins.

Claude’s Call

UP — The Iran de-escalation removes the biggest near-term tail risk, and with positioning still defensive after last week’s tech rotation, short covering and holiday-week FOMO should push the S&P 500 up 0.7-1.2% today.

Top Movers

FCEL (+26.78%) — $30.56 → $35.00 (+14.5% upside) Thesis: The +27% move is backed by a concrete catalyst — a $49M non-dilutive EXIM Bank financing package for a South Korean project, plus a Jefferies upgrade to Buy last Thursday. This is a classic “prove the business model” inflection for a company that’s struggled with dilution fears for years. The non-dilutive nature of the capital is what retail is celebrating. However, FCEL has already ripped ~50% in a few sessions, and with RSI at 50 (resetting from overbought), this could consolidate before another leg higher. Levels: Exit at $35 (prior resistance zone from early 2026 highs). Support at $24.50 (Friday’s pre-breakout level).

SLS (+11.69%) — $13.65 → $16.50 (+20.9% upside) Thesis: This is a short squeeze setup meeting M&A speculation — 33% short interest with executive severance updates that scream “takeover prep.” The stock has rallied 60% in a week on the buyout chatter, and XBI’s strongest monthly performance since Dec 2023 is providing biotech tailwinds. Dangerous to chase at +60% weekly, but if the acquisition materializes, this goes multiples higher. The short squeeze mechanics are real — this isn’t hopium. Levels: Exit at $16.50 (round number resistance, likely squeeze target). Support at $10.50 (Thursday’s close, 6-session rally base).

ABCL (+10.28%) — $8.15 → $9.50 (+16.6% upside) Thesis: The Jazz Pharmaceuticals collaboration ($56M upfront) validates AbCellera’s antibody discovery platform, and the stock hitting 52-week highs suggests institutional accumulation. The T-cell multispecific antibody space for solid tumors is a massive TAM. Up 42% on the week — extended but with real fundamental backing. This is the kind of platform company that re-rates when partnerships stack up. Levels: Exit at $9.50 (measured move from breakout). Support at $7.40 (pre-week breakout level).

AXON (+7.68%) — $499.35 → $560.00 (+12.1% upside) Thesis: Bouncing hard off deeply oversold levels (RSI 13.87 — that’s extreme) with multiple catalysts converging: Citizens reiterating $700 PT with 53% upside, Dedrone counter-drone expansion, and the politically charged Trump/ICE Taser contract news generating attention. The RSI reading suggests this was washed out and is now in mean-reversion mode. Quality name with AI-in-policing secular tailwind at a discount. Levels: Exit at $560 (50-day MA recovery target). Support at $463 (recent swing low).

APP (+4.92%) — $499.74 → $570.00 (+14.1% upside) Thesis: Citi maintaining Buy/$710 PT, software rotation tailwind, and the stock recovering from RSI of 1.0 (yes, literally the most oversold reading possible). The market rotation narrative from chips to software is the macro catalyst, and APP is an S&P 500 constituent with proven profitability. E-commerce ramp may be slower than expected post-Axon GA, but the core ad-tech engine is a cash machine. This is a buy-the-dip setup on one of 2025’s biggest winners. Levels: Exit at $570 (prior consolidation zone). Support at $446 (last week’s close/low).

MDB (+4.88%) — $329.11 → $365.00 (+10.9% upside) Thesis: FQ1 revenue of $687.6M (+25% YoY) with Atlas growing 29% — this is re-accelerating growth in the database space. RSI at 3.29 indicates this was catastrophically oversold (billionaire selling in Q1 created an air pocket that’s now filling). The fundamental story is intact — AI workloads need databases, and MongoDB is the developer-first choice. Buying at these RSI levels with growth accelerating is textbook. Levels: Exit at $365 (pre-selloff support turned resistance). Support at $313 (recent swing low).

RNG (+6.80%) — $39.41 → $44.00 (+11.6% upside) Thesis: RSI at 0.22 — this is statistically as oversold as a stock gets before it bounces. The AIR Pro agentic AI expansion with 1,700+ RingCX customers (half adopting AI) provides real fundamental support. UCaaS is out of favor, but at these levels, you’re buying a profitable cash-generating business at a massive discount to its 2024 range. Classic mean-reversion trade. Levels: Exit at $44 (20-day MA recovery). Support at $36.90 (52-week low area).

Headlines to Watch

  • U.S.-Iran agree to pause hostilities, meeting Tuesday in Qatar — Removes the oil/geopolitical risk premium that hit markets last week; energy names may give back gains while risk assets rally.
  • SpaceX added to Nasdaq-100 — The largest private-to-public index inclusion in history will force passive buying and sets precedent for future private company listings.
  • Trump bought Axon stock before ICE sought $220M Taser contract — Potential conflict-of-interest headline that could create volatility in AXON but also validates the government spending thesis.
  • Scott Bessent unveils “3 through 3” plan to beat structural inflation — Policy framework matters for rate expectations; signals administration focused on growth + inflation control simultaneously.
  • Software rotation accelerating: ServiceNow, Workday, AppLovin leading — The chip-to-software rotation is a positioning shift that could persist for weeks as AI narrative broadens beyond hardware.
  • VOO crosses $1 trillion AUM, nearly 40% is now tech — Concentration risk in passive vehicles means any tech downdraft gets amplified through forced selling; know what you own.
  • McCormick advancing Unilever Foods deal, expects EPS accretion — Major consumer staples M&A creating event-driven opportunity in defensive names.

Claude’s Top Picks

AXON (+7.68% today, +21.78% week) — $499.35 → $560.00 (+12.1% upside) Valuation: At ~50x forward earnings with 30%+ revenue growth and expanding AI/drone TAM, PEG ratio is ~1.6x — fair for a category-defining public safety platform with no true peer. Upside: RSI of 13.87 is a screaming oversold signal on a stock with $700 analyst targets and multiple catalysts (ICE contract, Dedrone, AI dispatch) still ahead. Risk: The Trump stock-purchase headline could trigger political scrutiny or an ethics investigation that creates overhang.

MDB (+4.88% today, +3.12% week) — $329.11 → $365.00 (+10.9% upside) Valuation: At ~48x forward earnings on 25% growth, PEG of ~1.9x is reasonable for the developer database leader; peers like Snowflake trade richer on slower growth. Upside: RSI at 3.29 with re-accelerating fundamentals — billionaire selling created a technical dislocation that’s correcting; Atlas growth at 29% proves AI workload tailwind is real. Risk: Billionaires were selling for a reason; if macro deteriorates, discretionary IT spending (including database modernization) gets cut first.

APP (+4.92% today, +6.47% week) — $499.74 → $570.00 (+14.1% upside) Valuation: One of the most profitable S&P 500 members with 50%+ operating margins; forward P/E is compelling relative to its growth rate and cash generation. Upside: Software rotation has legs as market broadens beyond chips; Citi’s $710 target implies 42% upside, and RSI at 1.0 means the selling was capitulatory. Risk: Citi flagged slower e-commerce client ramp post-Axon GA; if Q2 growth disappoints on that front, the premium multiple compresses quickly.

RNG (+6.80% today, +13.12% week) — $39.41 → $44.00 (+11.6% upside) Valuation: Trading at ~10x forward earnings with positive FCF — absurdly cheap for a UCaaS leader; peers like Zoom trade at similar multiples but with worse growth trajectory. Upside: AI capabilities (1,700+ RingCX customers) provide re-rating catalyst; RSI of 0.22 is as mathematically oversold as possible, suggesting forced selling is exhausted. Risk: UCaaS market is mature; if AI monetization doesn’t accelerate by next earnings, the value-trap narrative reasserts.

FCEL (+26.78% today, +25.28% week) — $30.56 → $35.00 (+14.5% upside) Valuation: Still speculative but the non-dilutive $49M financing changes the narrative from “serial diluter” to “project-funded growth” — a meaningful multiple re-rate if sustained. Upside: Data center power demand is a multi-year secular theme, and FCEL now has a funded project pipeline plus Jefferies upgrade providing institutional cover. Risk: One project doesn’t make a company; if no follow-on orders materialize in 60 days, the stock gives back most of this move.

Avoid

SLS (+11.69% today, +60.08% week) — Up 60% in a week on buyout speculation from an executive severance filing. If no deal materializes, this unwinds violently given 33% short interest works both ways — shorts can also reload at higher prices. The risk/reward at $13.65 is asymmetric to the downside unless you have conviction the deal is real.

BFLY (+6.47% today, +30.19% week) — The Midjourney partnership is exciting but early-stage (40 modules in a prototype); RSI at 75 is the only overbought stock in today’s top 20, and the company still isn’t profitable. The Michael Burry endorsement creates retail FOMO that tends to fade.

TRLV (+4.89% today, +1.48% week) — CEO selling $1.2M in stock after 148% annual gain while the stock trades on cannabis legalization hopes. Insider selling at this pace in a highly regulated, still federally-illegal industry is a yellow flag. The NYSE listing was the catalyst; now it’s priced in.

WSB Sentiment Check

MU — WSB says: BULLISH (80% bullish) Claude says: AGREE — Micron is the most direct HBM/AI memory play, and the “MANIA” trade narrative (replacing Mag 7) gives it fresh institutional framing. Memory cycle is inflecting higher, and MU historically runs into earnings on sentiment alone. Ride it but set stops.

MSFT — WSB says: BULLISH (80% bullish) Claude says: AGREE — Microsoft is the safest large-cap AI beneficiary with Azure growth re-accelerating and Copilot monetization still in early innings. Not exciting for a swing trade, but the consensus view is correct here.

WEN — WSB says: BULLISH (80% bullish, 4727 upvotes) Claude says: PARTIALLY DISAGREE — 4,700+ upvotes on a fast-food chain is suspicious WSB energy. The engagement is likely meme-driven (Wendy’s jokes are WSB culture). Unless there’s a real catalyst I’m not seeing, this is community engagement, not investment thesis. Be careful with high upvotes on low-quality setups.

UI — WSB says: BULLISH (80% bullish) Claude says: AGREE — Ubiquiti’s networking hardware benefits from data center buildout and has historically been a WSB favorite with legitimate fundamentals (high margins, capital-light model). The AI infrastructure theme provides real tailwind.

MSTR — WSB says: BULLISH (80% bullish) Claude says: PARTIALLY AGREE — MicroStrategy is a leveraged Bitcoin bet, and if BTC is rallying on risk-on sentiment (Iran de-escalation helps), MSTR amplifies that move. But it’s not a stock analysis — it’s a crypto trade with extra leverage and Saylor premium. Know what you’re buying.